This report presents data from DAWN to describe national estimates of polysubstance-involved emergency department (ED) visits in the United States in 2024. It provides estimates of polysubstance-involved ED visits by (1) patient characteristics, (2) psychoactive drug involved, and (3) co-occurrence (or combination) of psychoactive drugs.